View Older Stories

Apr 29, 2026 05:40PM Ionis Pharmaceuticals (IONS) PT Raised to $110 at Oppenheimer

Apr 29, 2026 04:10PM Ionis Pharmaceuticals (IONS) PT Raised to $86 at Stifel

Apr 29, 2026 07:10AM Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 29c ; Offers Guidance

Apr 26, 2026 08:00PM U.S. Biotech stocks: Q1 earnings previews

Apr 21, 2026 07:03AM Ionis reports positive zilganersen data for Alexander disease

Apr 9, 2026 04:28PM Raymond James Starts Ionis Pharmaceuticals (IONS) at Outperform, 'Taking Returns to Heart (and Mind)'

Mar 31, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Mar 25, 2026 05:45PM William Blair stays Outperform on Ionis Pharmaceuticals (IONS); pricing update 'positive'

Mar 25, 2026 03:58PM Ionis Pharmaceuticals (IONS) PT Raised to $106 at Barclays

Mar 25, 2026 03:42PM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)

Mar 25, 2026 12:24PM BofA Securities stays Buy on Ionis Pharmaceuticals (IONS) as new pricing 'a positive update'

Mar 25, 2026 11:44AM Ionis Pharmaceuticals (IONS) PT Raised to $83 at Stifel

Mar 25, 2026 10:58AM Ionis Pharmaceuticals (IONS) PT Raised to $120 at H.C. Wainwright

Mar 25, 2026 10:13AM Ionis Pharmaceuticals (IONS) PT Raised to $104 at Oppenheimer

Mar 25, 2026 10:12AM Ionis Pharmaceuticals (IONS) PT Raised to $114 at Leerink Partners

Mar 25, 2026 09:46AM Wolfe Research on Ionis Pharmaceuticals (IONS): new Tryngolza pricing likely to ‘squeeze’ Arrowhead’s rival drug

Mar 6, 2026 10:34AM Ionis Pharmaceuticals (IONS) March 70 and 75 puts as share price down 1%

Mar 5, 2026 01:10PM Ionis Pharmaceuticals (IONS) March 70 and 75 puts active, share price down 4.8%

Feb 27, 2026 07:02AM Ionis to present DAWNZERA data at 2026 AAAAI meeting

Feb 26, 2026 05:53AM Ionis Pharmaceuticals (IONS) PT Raised at Bernstein Ahead of a Catalyst-Rich 2H26

Feb 26, 2026 05:32AM Ionis Pharmaceuticals (IONS) PT Raised to $77 at Stifel

Feb 25, 2026 03:46PM Ionis Pharmaceuticals (IONS) PT Raised to $95 at Morgan Stanley

Feb 25, 2026 01:20PM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)

Feb 25, 2026 07:03AM Ionis Pharmaceuticals (IONS) Misses Q4 EPS by 8c, provides guidance

Feb 4, 2026 07:30AM BIOGEN publishes study results for high-dose nusinersen in Nature Medicine

Jan 21, 2026 07:00AM DAWNZERA gets European Commission approval for hereditary angioedema

Jan 12, 2026 11:06AM BIOGEN receives EU approval for high dose SPINRAZA for spinal muscular atrophy

Dec 17, 2025 05:28AM Ionis Pharmaceuticals (IONS) PT Raised to $95 at RBC Capital

Dec 3, 2025 08:26AM TD Cowen on Ionis Pharmaceuticals (IONS): 'New Launches And Key Pipeline Catalysts To Drive Upside'

Nov 17, 2025 06:02AM Biogen (BIIB): High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

Nov 14, 2025 07:01AM Ionis' DAWNZERA receives EU regulatory committee recommendation for HAE

Nov 13, 2025 02:00AM Ionis prices $700 million convertible notes to refinance 2026 debt

Nov 11, 2025 04:05PM Ionis announces $700 million convertible notes offering to refinance 2026 debt

Nov 11, 2025 07:39AM Bernstein on Ionis Pharmaceuticals (IONS): 'Very Positive Doc Call on SHTG Data'

Nov 10, 2025 07:30AM Ionis reports olezarsen cut triglyceride levels up to 72% in pivotal trials

Nov 6, 2025 08:02AM Ionis presents long-term DAWNZERA data at ACAAI meeting

Oct 30, 2025 05:55AM Ionis Pharmaceuticals (IONS) PT Raised to $99 at TD Cowen, Top Pick

Oct 30, 2025 05:37AM Ionis Pharmaceuticals (IONS) PT Raised to $72 at Leerink Partners

Oct 29, 2025 07:08AM Ionis Pharmaceuticals (IONS) Tops Q3 EPS by 42c, Beats on Revenue; Offers FY25 EPS Guidance

Oct 27, 2025 07:41AM Bernstein's US Biotech 3Q25 Preview: 'Expect Beats from ALNY and REGN'

Oct 9, 2025 09:26AM TD Cowen on Ionis Pharmaceuticals (IONS): 'Deep Cardio & Neuro Pipelines Set Up Continued Revs Growth'

Oct 9, 2025 05:20AM Ionis Pharmaceuticals (IONS) PT Raised to $85 at Raymond James

Oct 8, 2025 08:04AM Ionis (IONS) Hold rating reiterated at Stifel after Innovation Day presentation

Oct 8, 2025 06:37AM Ionis Pharmaceuticals (IONS) PT Raised to $90 at Oppenheimer

Oct 8, 2025 03:04AM JPMorgan Upgrades Ionis Pharmaceuticals (IONS) to Overweight

Oct 7, 2025 07:03AM Ionis hosts innovation day, targets sustained cash flow by 2028

Oct 6, 2025 09:20AM Ionis Pharmaceuticals (IONS) PT Raised to $67 at Stifel

Sep 26, 2025 05:06AM Goldman Sachs Upgrades Ionis Pharmaceuticals (IONS) to Neutral

Sep 24, 2025 04:15AM Ionis Pharmaceuticals (IONS) PT Raised to $68 at Leerink Partners

Sep 23, 2025 04:30PM FDA requests technical updates for Biogen's high dose nusinersen application

View Older Stories